Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Clinical trial NCT03219320 · COMPLETED
Trial details
- NCT number
- NCT03219320
- Sponsor
- Aptinyx
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2018-11-02
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.